文献速递肥胖与代谢综合征

减重手术后贫血的长期风险:瑞典肥胖受试者研究结果

Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2021-07-01

该前瞻性对照瑞典肥胖受试者研究纳入2007例选择减重手术者与2040例匹配常规照护对照,随访最长20年、中位10年。与对照组相比,胃旁路术、垂直带状胃成形术和胃束带术的贫血发病率均显著升高,且校正后关联仍存在。

要点

  • 减重手术后贫血长期风险显著高于常规肥胖照护。
  • 胃旁路术贫血风险最高,垂直带状胃成形术和胃束带术亦升高。
  • 术后需长期依从营养补充和监测以预防及早期发现贫血。

核心结论

  • 减重手术后贫血风险增加,应重视长期营养补充依从性与监测。

研究设计与样本

  • 前瞻性对照的瑞典肥胖受试者研究,在480家初级保健中心和25个外科部门招募37-60岁、BMI达标的肥胖者。
  • 纳入2007例选择减重手术者(胃旁路术266例、垂直带状胃成形术1365例、胃束带术376例)和2040例匹配常规肥胖照护对照。
  • 随访最长20年、中位10年,按治疗人群分析贫血发病率。

主要发现

  • 随访期间贫血事件:胃旁路术组133例、垂直带状胃成形术组359例、胃束带术组101例、对照组261例。
  • 校正年龄、性别、BMI、绝经状态、教育、糖尿病和高血压后,关联仍存在。

关键数值与推荐

  • 贫血定义为女性血红蛋白<120 g/L、男性<130 g/L。
  • 主要结局为贫血发病率,在仅接受实际治疗的治疗人群中进行评估。

临床怎么用

  • 减重手术后应长期监测血红蛋白并评估贫血风险。
  • 强调术后长期依从营养补充,以预防和早期发现严重营养缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nutritional deficiencies, such as iron and vitamin B12 deficiencies, are potential adverse consequences of bariatric surgery. Long-term data on anaemia after bariatric surgery are largely lacking. We aimed to investigate the risk of anaemia, iron and vitamin B12 deficiency anaemia, and vitamin B12 deficiency over 20 years in individuals who had bariatric surgery or received usual obesity care. METHODS: The prospective, controlled Swedish Obese Subjects study recruited people with obesity via recruitment campaigns in the mass media and at primary health-care centres, and was done at 480 primary health-care centres and in 25 surgical departments in Sweden. Eligible participants were aged 37-60 years and had a BMI of either 34 kg/m2 or more (for men) or 38 kg/m2 or more (for women). Participants were excluded if they had undergone previous bariatric surgery or had contraindicating conditions. Two main groups were formed: those who chose bariatric surgery, the type of which was determined by the operating surgeon, and a contemporaneously matched control group, created by use of 18 matching variables, who received usual non-surgical obesity care that ranged from lifestyle advice to no treatment. Haemoglobin concentration was measured during examination visits at baseline and at 1 year, 2 years, 3 years, 4 years, 6 years, 8 years, 10 years, 15 years, and 20 years of follow-up. Anaemia was defined as a haemoglobin concentration of less than 120 g/L for women and 130 g/L for men. The primary, non-specified outcome was the incidence of anaemia, and was assessed in the as-treated population, which comprised only patients who received the actual treatment. The associations between treatment type and anaemia are expressed as unadjusted hazard ratios (HRs) and HRs adjusted for age, sex, BMI, menopausal status, education, diabetes, and hypertension, with 95% CIs. This study is registered in ClinicalTrials.gov, NCT01479452, and is closed to new participants, with follow-up ongoing. FINDINGS: Between Sept 1, 1987, and Jan 31, 2001, 6905 individuals were assessed for eligibility, of whom 5335 were eligible. Of these, we included 2007 patients who chose bariatric surgery (266 in the gastric bypass group, 1365 in the vertical-banded gastroplasty group, and 376 in the gastric banding group) and 2040 matched controls who received usual obesity care. During a maximum of 20 years and a median of 10 years (IQR 3-20) of follow-up, there were 133 anaemia events in the gastric bypass group, 359 in the vertical-banded gastroplasty group, 101 in the gastric banding group, and 261 in the control group. Compared with the control group (13 cases per 1000 person-years, 95% CI 11-14), the incidence of anaemia was higher in the gastric bypass group (64 cases per 1000 person-years, 53-74; HR 5·05, 95% CI 3·94-6·48; p<0·0001), the vertical-banded gastroplasty group (23 cases per 1000 person-years, 21-26; 2·67, 2·25-3·18; p<0·0001), and the gastric banding group (26 per 1000 person-years, 21-31; 2·76, 2·15-3·52; p<0·0001). These associations remained after adjustment. INTERPRETATION: Our findings highlight the increased risk of anaemia after bariatric surgery and the importance of long-term compliance to nutritional supplementation and monitoring to enable prevention and early detection of serious nutritional deficiencies after bariatric surgery. FUNDING: Swedish Research Council, the Swedish state under the agreement between the Swedish Government and the county councils, the Swedish Diabetes Foundation, the Swedish Heart-Lung Foundation, and the Novo Nordisk Foundation.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Johansson K, Svensson PA, Söderling J, et al. Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2021. PMID: 34217404. doi:10.1016/S2213-8587(21)00141-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。